These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8038480)

  • 21. Medicaid program; limitations on aggregate payments to disproportionate share hospitals; Federal Fiscal Year 1993--HCFA. Notice.
    Fed Regist; 1993 Aug; 58(155):43184-7. PubMed ID: 10128081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing Medical reimbursement for out-of-state providers.
    Johnson DL
    Healthc Financ Manage; 1997 May; 51(5):66, 68, 71. PubMed ID: 10167298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creative payment strategy helps ensure a future for teaching hospitals.
    Vancil DR; Shroyer AL
    Healthc Financ Manage; 1998 Nov; 52(11):48-52. PubMed ID: 10187630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varying health care provider objectives and cost-shifting: the case of retail pharmacy in the US.
    Brooks JM; Sorofman B; Doucette W
    Health Econ; 1999 Mar; 8(2):137-50. PubMed ID: 10342727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adequacy of physician reimbursement for pediatric care under Medicaid.
    McManus M; Flint S; Kelly R
    Pediatrics; 1991 Jun; 87(6):909-20. PubMed ID: 2034498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicaid Capitation Payments by State.
    Hsia DC
    Inquiry; 2019; 56():46958019892882. PubMed ID: 31823662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a managed care delivery system in New York State for Medicaid recipients with HIV.
    Feldman I; Cruz H; DeLorenzo J; Hidalgo J; Plavin H; Whitaker J
    Am J Manag Care; 1999 Nov; 5(11):1457-65. PubMed ID: 10662420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
    Soumerai S
    J Clin Psychiatry; 2003; 64 Suppl 17():19-22. PubMed ID: 14680423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eligibility policies for the state AIDS drug assistance programs.
    Buchanan RJ; Chakravorty BJ; Smith SR
    Soc Work Health Care; 2001; 32(3):81-104. PubMed ID: 11358274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect Spending.
    Ippolito B; Levy JF; Anderson GF
    Health Aff (Millwood); 2020 Jul; 39(7):1202-1209. PubMed ID: 32634350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives. States use upper payment limit to snag federal Medicaid dollars.
    Clemmitt M
    Med Health; 2000 Nov; 54(45):suppl 1-4. PubMed ID: 11186857
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicaid program; limitations on provider-related donations and health care-related taxes; limitations on payments to disproportionate share hospitals--HCFA. Final rule.
    Fed Regist; 1993 Aug; 58(155):43156-83. PubMed ID: 10128080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-assistance programs funded by Title II of the Ryan White CARE Act: a survey of the states.
    Buchanan RJ; Smith SR
    AIDS Public Policy J; 1996; 11(4):185-203. PubMed ID: 10915252
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicaid cuts threaten care for people with AIDS.
    Donnelly A
    PI Perspect; 1995 Dec; (no 17):7. PubMed ID: 11363112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.
    Soumerai SB; McLaughlin TJ; Ross-Degnan D; Casteris CS; Bollini P
    N Engl J Med; 1994 Sep; 331(10):650-5. PubMed ID: 8052275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing a managed care delivery system for people with HIV/AIDS.
    Singer B; Gamliel S; Conviser R
    Am J Manag Care; 1999 Nov; 5(11):1443-7. PubMed ID: 10662418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicaid cost containment and access to prescription drugs.
    Cunningham PJ
    Health Aff (Millwood); 2005; 24(3):780-9. PubMed ID: 15886173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. States rebut AHA's gloomy Medicaid-payment rundown.
    Greene J; Burda D
    Mod Healthc; 1991 Jul; 21(30):12. PubMed ID: 10111861
    [No Abstract]   [Full Text] [Related]  

  • 39. Adolescent use of Norplant implants: clinic services, policies and barriers to use.
    Frost JJ; Kaeser L
    J Adolesc Health; 1995 May; 16(5):367-72. PubMed ID: 7662686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicaid program: final limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1997--HCFA. Notice.
    Fed Regist; 1997 Sep; 62(178):48292-7. PubMed ID: 10173797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.